Evidence map›Paper›PMID 35170965›Full record

ArticleMolecular pharmaceutics2022

Pharmacokinetic Modeling of [

Nafiseh Ghazanfari, Aren van Waarde, Janine Doorduin, Jürgen W A Sijbesma, Maria Kominia, Martin Koelewijn, Khaled Attia, Antoon T M Willemsen, Ton J Visser, André Heeres and 3 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Nafiseh GhazanfariUniversity Medical Center Groningen, Department of Nuclear Medicine and Molecular Imaging, University of Groningen, Groningen 9700 RB, The Netherlands.
Aren van WaardeUniversity Medical Center Groningen, Department of Nuclear Medicine and Molecular Imaging, University of Groningen, Groningen 9700 RB, The Netherlands.
Janine DoorduinUniversity Medical Center Groningen, Department of Nuclear Medicine and Molecular Imaging, University of Groningen, Groningen 9700 RB, The Netherlands.
Jürgen W A SijbesmaUniversity Medical Center Groningen, Department of Nuclear Medicine and Molecular Imaging, University of Groningen, Groningen 9700 RB, The Netherlands.
Maria KominiaUniversity Medical Center Groningen, Department of Nuclear Medicine and Molecular Imaging, University of Groningen, Groningen 9700 RB, The Netherlands.
Martin KoelewijnSymeres, Groningen 9747 AT, The Netherlands.
Khaled AttiaUniversity Medical Center Groningen, Department of Nuclear Medicine and Molecular Imaging, University of Groningen, Groningen 9700 RB, The Netherlands.
Antoon T M WillemsenUniversity Medical Center Groningen, Department of Nuclear Medicine and Molecular Imaging, University of Groningen, Groningen 9700 RB, The Netherlands.
Ton J VisserSymeres, Groningen 9747 AT, The Netherlands.
André HeeresSymeres, Groningen 9747 AT, The Netherlands.
Rudi A J O DierckxUniversity Medical Center Groningen, Department of Nuclear Medicine and Molecular Imaging, University of Groningen, Groningen 9700 RB, The Netherlands.
Erik F J de VriesUniversity Medical Center Groningen, Department of Nuclear Medicine and Molecular Imaging, University of Groningen, Groningen 9700 RB, The Netherlands.
Philip H ElsingaUniversity Medical Center Groningen, Department of Nuclear Medicine and Molecular Imaging, University of Groningen, Groningen 9700 RB, The Netherlands.ORCID 0000-0002-3365-4305
University Medical Center Groningen · NLFlevoziekenhuis · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The histamine H

Indexed as

Neurodegenerative DiseasesAnimalsBenzazepinesBrainCarrier ProteinsHistamineNiacinamidePositron-Emission TomographyRadiopharmaceuticalsRatsRats, Wistar6-((3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy)-N-methyl-3-pyridinecarboxamideBenzazepinesCarrier ProteinsHistamineNiacinamideRadiopharmaceuticals[11C]GSK189254Histamine H3 receptorkinetic modelingpharmacokineticsreceptor imaging

Identifiers

PMID35170965
PMCPMC8905578
OpenAlexW4213290487

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.